Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06636474

Evaluation of the Supported Housing System for the Inclusion of People Suffering From Mental Disorders

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Centre Hospitalier St Anne · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Access to housing, in the current context of extreme tension in the rental housing market in Paris and throughout the Ile-de-France region, is proving to be extremely complex for people with mental health problems.National and international scientific studies have quantified the problem of homelessness and precarious or inappropriate housing among patients suffering from psychiatric disorders, and show the impact of housing problems on the consumption of psychiatric care.The DÉLAI's mission is to facilitate access to housing for people enrolled in a psychiatric care pathway, with teams from the psychiatric sectors

Detailed description

* Written and oral information provided to the patient by the patient's referring psychiatrist (Investigator of one of the five recruiting sites) during a regular consultation appointment. * Initial assessment (V inclusion): reminder of the information concerning the research, collection of consent, collection of sociodemographic data, and standardized assessment scales (quality of life, clinical state, level of functioning) + standardized semi-structured interview for the diagnosis of psychiatric disorders + completion by the referring psychiatrist of the data corresponding to the patient's care pathway. * Then follow-up visit at an annual rate (V1 ... VX), and DLAI exit assessment (V exit) as soon as the patient stops benefiting from the DLAI.

Conditions

Interventions

TypeNameDescription
OTHERpatients with mental disordersadministration of standardized questionnaires and scales, upon entering the research, then annually, and finally upon leaving the research

Timeline

Start date
2020-07-27
Primary completion
2030-07-27
Completion
2030-12-27
First posted
2024-10-10
Last updated
2024-10-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06636474. Inclusion in this directory is not an endorsement.